Applied DNA Sciences, Inc. (NASDAQ:APDN) Files An 8-K Regulation FD DisclosureItem 7.01
LineaRx, Inc., a wholly-owned subsidiary of Applied DNA Sciences, Inc. (“Applied DNA”) will provide a presentation to the investment community via an analyst day webinar to be held today, December 6, 2018 at 12pm EST. A copy of the presentation materials to be used by Applied DNA Sciences, Inc. during its presentation is furnished as Exhibit 99.1 to this Current Report on 8-K and is incorporated by reference herein. Such materials along with an audio recording of the webinar (expected to be available several hours after the conclusion of the webinar) will also be available on Applied DNA’s website (www.adnas.com).
The information in Item 7.01of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise stated in such filing. All information in the presentation materials speak as of the date thereof, and Applied DNA does not assume any obligation to update such information in the future. In addition, Applied DNA disclaims any inference regarding the materiality of such information which otherwise may arise as a result of its furnishing such information under Item 7.01 of this Current Report on 8-K.
|Item 9.01||Financial Statements and Exhibits.|
99.1 Materials to be presented December 6, 2018 (furnished with the Commission as part of this Form 8-K)
APPLIED DNA SCIENCES INC ExhibitEX-99.1 2 tv508538_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Analyst Day December 2018 2 Forward Looking Statements This presentation and various remarks made during this presentation may be “forward – looking” in nature within the meaning of the Private Securities Litigation Act of 1995 . Forward – looking statements describe Applied DNA’s future plans,…To view the full exhibit click
About Applied DNA Sciences, Inc. (NASDAQ:APDN)
Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company’s platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.